Obesity drugs: huge study highlights new health risks
NatureJAN 21
Weight-Loss Drugs Show Broad Health Benefits Amid Safety Concerns
Above: Weight loss syringes of the brands Wegovy, Ozempic, and Mounjaro. Image credit: Jens Kalaene/Contributor/picture alliance via Getty Images
The Spin
Narrative A
This groundbreaking study demonstrates that GLP-1 medications offer far more benefits than just weight loss, with significant potential to treat multiple conditions. This makes them valuable tools in addressing various health challenges beyond obesity.
Narrative B
Despite their promising benefits, these medications also carry serious risks, including potentially fatal complications. They're not miracle drugs and require careful monitoring and individualized risk-benefit analysis before being prescribed.